Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
97.02
-0.77 (-0.79%)
Mar 13, 2026, 4:00 PM EDT - Market closed

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
United States Revenue
375.04M270.09M
United States Revenue Growth
38.86%23.11%
International Revenue
132.40M113.39M
International Revenue Growth
16.77%18.96%
Revenue (Total)
507.44M383.48M
Revenue (Total) Growth
32.32%21.85%

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Glaucoma Revenue
421.07M303.28M
Glaucoma Revenue Growth
38.84%27.94%
Corneal Health Revenue
86.37M80.21M
Corneal Health Revenue Growth
7.69%3.26%
Revenue (Total)
507.44M383.48M
Revenue (Total) Growth
32.32%21.85%
Updated Dec 31, 2025. Data Source: Fiscal.ai.